vimarsana.com

Latest Breaking News On - Fusn phar stock exchange - Page 1 : vimarsana.com

Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAMILTON, ON and BOSTON, June 7, 2023 /PRNewswire/ Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision. | June 7, 2023

Boston
Massachusetts
United-states
Amanda-cray
Investor-relations-corporate-communications
Fusion-pharmaceuticals
Niowave-inc
Company-board-of-directors
Astrazeneca
Nasdaq
Prnewswire-fusion-pharmaceuticals-inc
Nasdaq-listing-rule

Fusion Pharmaceuticals to Present at the Jefferies Healthcare Conference

HAMILTON, ON and BOSTON, May 31, 2023 /PRNewswire/ Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision. | May 31, 2023

Boston
Massachusetts
United-states
Amanda-cray
John-valliant
Prnewswire-fusion-pharmaceuticals-inc
Niowave-inc
Nasdaq
Investor-relations-corporate-communications
Fusion-pharmaceuticals
Astrazeneca
Jefferies-healthcare-conference

vimarsana © 2020. All Rights Reserved.